Short Interest in Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) Grows By 67.4%

Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABDGet Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totaling 1,282,116 shares, a growth of 67.4% from the March 15th total of 765,827 shares. Currently, 20.3% of the shares of the stock are short sold. Based on an average trading volume of 5,967,409 shares, the short-interest ratio is currently 0.2 days.

Hedge Funds Weigh In On Direxion Daily S&P Biotech Bear 3x Shares

Several institutional investors have recently bought and sold shares of the stock. Jump Financial LLC grew its stake in Direxion Daily S&P Biotech Bear 3x Shares by 107.7% during the second quarter. Jump Financial LLC now owns 174,239 shares of the company’s stock valued at $1,303,000 after acquiring an additional 90,333 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in Direxion Daily S&P Biotech Bear 3x Shares during the third quarter valued at $5,063,000. Group One Trading LLC purchased a new position in Direxion Daily S&P Biotech Bear 3x Shares during the second quarter valued at $337,000. Tower Research Capital LLC TRC grew its stake in Direxion Daily S&P Biotech Bear 3x Shares by 87.9% during the second quarter. Tower Research Capital LLC TRC now owns 41,202 shares of the company’s stock valued at $308,000 after acquiring an additional 19,276 shares in the last quarter. Finally, Qube Research & Technologies Ltd purchased a new position in Direxion Daily S&P Biotech Bear 3x Shares during the third quarter valued at $983,000.

Direxion Daily S&P Biotech Bear 3x Shares Stock Performance

LABD traded down $0.89 during trading on Monday, hitting $14.71. 6,403,689 shares of the company traded hands, compared to its average volume of 4,018,272. The stock’s 50-day simple moving average is $18.26 and its two-hundred day simple moving average is $22.93. Direxion Daily S&P Biotech Bear 3x Shares has a 1 year low of $14.15 and a 1 year high of $111.50.

Direxion Daily S&P Biotech Bear 3x Shares Company Profile

(Get Free Report)

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.

See Also

Receive News & Ratings for Direxion Daily S&P Biotech Bear 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bear 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.